eRoundup for 10/10/08
Atlanta Clinical & Translational
Science Institute (ACTSI)
Weekly eRoundup
October 10, 2008
Monday: Oragene™ DNA and Oragene™ RNA Self-Collection Kits Seminar
This seminar will focus on challenges and solutions for collecting DNA and RNA samples, including an overview of how Oragene products can integrate into your workflow from collection to genetic analysis. All participants will receive complimentary test kits.
When: Monday, October 13, 8:30-9:30 a.m. (40 minute presentation + Q&A)
Where: Emory University, Department of Neurology, Whitehead Biomedical Research Building, Room #400 (615 Michael Street, Atlanta, GA)
For further information about Oragene, please visit www.dnagenotek.com.
KL2-Clinical Research Career Development Program for Junior Faculty Members Request for Application-Deadline February 1, 2009
Junior faculty members at the MD or PhD level from a wide variety of disciplines at Emory University, Morehouse School of Medicine, or Georgia Tech who are committed to an academic career in clinical and/or translational research and who have excellent potential to become independent clinical investigators are encouraged to apply to the KL2-Mentored Clinical and Translational Research Scholars (MCTRS) Program. The KL2 award provides support for didactic and mentored research training for junior faculty members committed to a career in clinical investigation. The KL2 award includes 75% salary support per year for the junior faculty member, a technical budget for research costs and tuition, and some salary support for the trainee's Lead Mentor.
The KL2-MCTRS Program (formerly K12 program) is part of the Research Education, Training and Career Development (RETCD) Program supported by the Atlanta Clinical and Translational Science Institute (ACTSI), NIH Clinical and Translational Science Award (CTSA).
Please see the program's Web site for more details. Those interested in applying are urged to contact Cheryl Sroka at the ACTSI RETCD program office at 404-727-5096.
PhD Graduate Students and Medical Students Interested in Clinical and/or Translational Research-Dual Degree Program
The Research Education, Training, and Career Development (RETCD) program of the NIH-funded Atlanta Clinical and Translational Science Institute (ACTSI) announces new opportunities for clinical and translational research training for PhD graduate students (PhD/MSCR predoctoral track) and medical students. Students enrolled at Emory, Morehouse School of Medicine (MSM) and Georgia Tech (GT) are eligible. The goal of the program is to provide novel training for PhD graduate students or medical students with outstanding potential for careers in clinical and/or translational research.
Application must be submitted electronically by email, and are due no later than March 1, 2009. For PhD graduate students please visit this site; for medical students please visit this site. For more information visit www.actsi.org/retcd.
Medical and Graduate Students Interested in Clinical and/or Translational Research-Short-Term Training Opportunity
Current medical students at Emory University School of Medicine, Morehouse School of Medicine (MSM), and other health professional trainees pursuing doctoral degrees in public health, biomedical engineering, nursing and other fields at Emory, MSM and Georgia Tech can apply for short-term (3 month) stipends ($5,190 of salary support during this 3-month training period) funded by the Research Education, Training and Career Development (RETCD) program of the NIH-funded Atlanta Clinical and Translational Science Institute (ACTSI). This mechanism will support medical and graduate students who are interested in a short course program focused on clinical and/or translational research under the mentorship of a successful, federally funded faculty mentor.
Application for the short-term training program includes several components that should be submitted electronically by email. For more information please visit or www.actsi.org/retcd.
Request for Applications: New Technologies Investments
The Translational Technologies and Resources (TTR) program of the Atlanta Clinical and Translational Science Institute (ACTSI) is pleased to announce a request for applications (RFA) to use available funds for new technologies investments. Proposals must be submitted by 5:00 p.m. on Friday, October 31. For more information please visit.
Upcoming William E. Mitch Lecture by Dr. Peter Agre
Dr. Jeff M. Sands, ACTSI senior Co-PI, hosts Dr. Peter Agre as the William E. Mitch Lecturer in Nephrology on November 18, at 5:00 p.m. in the Emory University School of Medicine, rooms 110 and 120. Dr. Agre won the 2003 Nobel Prize in Chemistry for his cloning of the first water channel, Aquaporin-1. He is a professor at Johns Hopkins and heads their Malaria Research Institute.
NIH Announces Change in Resubmission (Amended) Applications Policy
The NIH released a new policy that will enhance success rates of new and resubmitted applications by decreasing the number of allowed grant application resubmissions from two to one. The new policy applies to all NIH grant programs. Below are key excerpts from the Guide
Notice:
Beginning with applications intended for the January 25, 2009 due date, all original new applications (i.e., never submitted) and competing renewal applications will be permitted only a single amendment (A1). For this and subsequent cohorts of original new and competing renewal applications, any second amendment (A2) will be administratively withdrawn and not accepted for review. Applicants who fail to receive funding after two submissions may resubmit but only if the application is fundamentally revised to qualify as new. A new application is expected to be substantially different in content and scope with more significant differences than are normally encountered in an amended application. Note that there is no time limit for the submission of the original and subsequent A1.
Original new and competing renewal applications that were submitted prior to January 25, 2009 will be permitted two amendments (A1 and A2). For these "grandfathered" applications, NIH expects that any A2 will be submitted no later than January 7, 2011, and NIH will not accept A2 applications after that date.